STEPSTONE GROUP INC. (STEP) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 86.08%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 86.08% | Share-based compensation / revenue. Period ending 2026-06-30. $1.73B ÷ $2.01B × 100 ≈ 86.08% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 2.01B USD | |
| Stock-based compensation | 1.73B USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.01B | $1.73B | (m) | (m) | (m) | 86.08% | (m) | (m) |
| 2026-03-31 | (m) | $1.99B | $1.62B | (m) | (m) | (m) | 81.14% | (m) | (m) |
| 2025-12-31 | (m) | $1.78B | $1.56B | (m) | (m) | (m) | 87.39% | (m) | (m) |
| 2025-09-30 | (m) | $1.54B | $1.65B | (m) | (m) | (m) | 107.72% | (m) | (m) |
| 2025-06-30 | (m) | $1.35B | $813.24M | (m) | (m) | (m) | 60.12% | (m) | (m) |
| 2025-03-31 | (m) | $1.17B | $650.13M | (m) | (m) | (m) | 55.34% | (m) | (m) |
| 2024-12-31 | (m) | $1.15B | $540.64M | (m) | (m) | (m) | 46.85% | (m) | (m) |
| 2024-09-30 | (m) | $800.28M | $78.58M | (m) | (m) | (m) | 9.82% | (m) | (m) |
| 2024-06-30 | (m) | $720.02M | $49.52M | (m) | (m) | (m) | 6.88% | (m) | (m) |
| 2024-03-31 | (m) | $711.63M | $39.45M | (m) | $9.33M | (m) | 5.54% | (m) | Reported |
| 2023-12-31 | (m) | $527.20M | $37.93M | (m) | $8.36M | (m) | 7.19% | (m) | Reported |
| 2023-09-30 | (m) | $537.57M | $31.83M | (m) | $6.91M | (m) | 5.92% | (m) | Reported |
| 2023-06-30 | (m) | $187.66M | $29.70M | (m) | $5.61M | (m) | 15.83% | (m) | Reported |
| 2023-03-31 | (m) | $-67.57M | $24.94M | (m) | $4.19M | (m) | -36.91% | (m) | Reported |
| 2022-12-31 | (m) | $124.74M | $19.24M | (m) | $2.99M | (m) | 15.42% | (m) | Reported |
| 2022-09-30 | (m) | $539.44M | $14.54M | (m) | $2.42M | (m) | 2.69% | (m) | Reported |
| 2022-06-30 | (m) | $979.70M | $13.97M | (m) | $1.69M | (m) | 1.43% | (m) | Reported |
| 2022-03-31 | (m) | $1.37B | $14.00M | (m) | $1.11M | (m) | 1.02% | (m) | Reported |
| 2021-12-31 | (m) | $1.36B | $13.62M | (m) | $644.00K | (m) | 1.00% | (m) | Reported |
| 2021-09-30 | (m) | $1.20B | $13.42M | (m) | $127.00K | (m) | 1.12% | (m) | Reported |
| 2021-06-30 | (m) | $1.16B | $11.16M | (m) | $5.31M | (m) | 0.96% | (m) | Reported |
| 2021-03-31 | (m) | $787.72M | $7.90M | (m) | $7.36M | (m) | 1.00% | (m) | Reported |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $446.61M | $1.92M | (m) | $10.21M | (m) | 0.43% | (m) | Reported |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $256.27M | $1.73M | (m) | $10.26M | (m) | 0.67% | (m) | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.